The Epithelial-Mesenchymal Transition (EMT) Regulatory Factor SLUG (SNAI2) Is a Downstream Target of SPARC and AKT in Promoting Melanoma Cell InvasionNina Fenouille, Sophie Tartare‐Deckert|PLoS ONE|2012Cited by 223
P2RY2-AKT activation is a therapeutically actionable consequence of XPO1 inhibition in acute myeloid leukemiaKevin Lin, Kris C. Wood, Hazel X. Ang et al.|Nature Cancer|2022Cited by 42
The Folate Cycle Enzyme MTHFR Is a Critical Regulator of Cell Response to MYC-Targeting TherapiesAngela Su, Alexandre Puissant, Frank Ling et al.|Cancer Discovery|2020Cited by 26
Targeting a lineage-specific PI3Kɣ–Akt signaling module in acute myeloid leukemia using a heterobifunctional degrader moleculeLoïs Kelly, Alexandre Puissant, Justine C. Rutter et al.|Nature Cancer|2024Cited by 25
A multiparametric niche-like drug screening platform in acute myeloid leukemiaReinaldo Dal Bello, Raphaël Itzykson, Justine Pasanisi et al.|Blood Cancer Journal|2022Cited by 13